Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1554-2016Class II

Pentra C400 (version 1.1.2 or lower) The ABX PENTRA 400 and 400C are discrete photometric bench top chemistry...

Horiba Instruments Incorporated / initiated 2016-02-19 / Terminated / root cause: software

Horiba Instruments Inc began a recall of Pentra C400 (version 1.1.2 or lower) The ABX PENTRA 400 and 400C are discrete photometric bench top chemistry analyzers for clinical use. The device is... on . FDA classified it as Class II and gives the reason as "Horiba Instruments, Inc. is recalling ABX Pentra 400( version 5.0.8 or lower) and Pentra C400 (version 1.1.2 or lower) because clinical chemistry analyzer malfunctions when the following certain alarms appear on the...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1554-2016
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Horiba Instruments Incorporated
Product
Pentra C400 (version 1.1.2 or lower) The ABX PENTRA 400 and 400C are discrete photometric bench top chemistry analyzers for clinical use. The device is intended to duplicate manual analytical procedures by performing various steps such as pipetting, mixing, heating and measuring color intensity. The device is intended for use in conjunction with certain materials to measure a variety of analytes.
Product code
JJE Analyzer, Chemistry (Photometric, Discrete), For Clinical Use
Reason for recall
Horiba Instruments, Inc. is recalling ABX Pentra 400( version 5.0.8 or lower) and Pentra C400 (version 1.1.2 or lower) because clinical chemistry analyzer malfunctions when the following certain alarms appear on the system.
Root cause tag
software
FDA root cause
Software design
Action
HORIBA Medical sent an "Urgent Safety Notice" dated February 19, 2016, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. A new software version to solve the issue is currently under development; however the firm requests customers use the provided procedure until the new software version is installed on the system, or be extremely vigilant with results of one of the alarms mentioned appears on the system. The letter instructs customers to share the information with laboratory staff and retain the notification as part of laboratory documentation. The letter states it is mandatory for customers to complete and return the enclosed response form within 10 days, in order to verify understanding of it. Any questions or concerns contact the local Horiba Medical representative. For further questions, please call (949) 250-4811.
Quantity in commerce
201
Distribution
USA (nationwide Distribution) to the states of : CA, NY, AL,OK, MS, MD, NV, MN, TX, KY, WV, MI, NY, MT, IL, FL,WA, ID, MO, WY, NJ, VA, KY, GA, PA, TN, MS, KS, AZ, NE, SC, OR, OH, IA, RI, MI and NC.
Product codes and lots
All lot/serial #s

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1554-2016
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1553-2016Class IITerminatedVoluntary: Firm initiated
Z-1554-2016Class IITerminatedVoluntary: Firm initiated